Overview

The marketing authorisation for Slentrol has been withdrawn at the request of the marketing authorisation holder.

Slentrol : EPAR - Summary for the public

български (BG) (279.69 KB - PDF)
español (ES) (239.85 KB - PDF)
čeština (CS) (283.94 KB - PDF)
dansk (DA) (239 KB - PDF)
Deutsch (DE) (241.8 KB - PDF)
eesti keel (ET) (237.14 KB - PDF)
ελληνικά (EL) (282.67 KB - PDF)
français (FR) (245.68 KB - PDF)
italiano (IT) (238.08 KB - PDF)
latviešu valoda (LV) (283.06 KB - PDF)
lietuvių kalba (LT) (251.47 KB - PDF)
magyar (HU) (253.42 KB - PDF)
Malti (MT) (265.77 KB - PDF)
Nederlands (NL) (217.72 KB - PDF)
polski (PL) (282.55 KB - PDF)
português (PT) (218.29 KB - PDF)
română (RO) (242.81 KB - PDF)
slovenčina (SK) (260.4 KB - PDF)
slovenščina (SL) (252.65 KB - PDF)
Suomi (FI) (237.94 KB - PDF)
svenska (SV) (239.22 KB - PDF)

Product information

Slentrol : EPAR - Product Information

български (BG) (1.12 MB - PDF)
español (ES) (413.23 KB - PDF)
čeština (CS) (559.01 KB - PDF)
dansk (DA) (619.26 KB - PDF)
Deutsch (DE) (409.78 KB - PDF)
eesti keel (ET) (394.94 KB - PDF)
ελληνικά (EL) (1.78 MB - PDF)
français (FR) (455.26 KB - PDF)
íslenska (IS) (418.64 KB - PDF)
italiano (IT) (432.39 KB - PDF)
latviešu valoda (LV) (543.86 KB - PDF)
lietuvių kalba (LT) (475.04 KB - PDF)
magyar (HU) (577.53 KB - PDF)
Malti (MT) (631.26 KB - PDF)
Nederlands (NL) (419.67 KB - PDF)
norsk (NO) (405.73 KB - PDF)
polski (PL) (601.64 KB - PDF)
português (PT) (402.62 KB - PDF)
română (RO) (490.98 KB - PDF)
slovenčina (SK) (616.03 KB - PDF)
slovenščina (SL) (568.91 KB - PDF)
Suomi (FI) (408.3 KB - PDF)
svenska (SV) (413.86 KB - PDF)

Latest procedure affecting product information: IAIN/0007/G

15/01/2015

Slentrol : EPAR - All Authorised presentations

български (BG) (202.54 KB - PDF)
español (ES) (148.22 KB - PDF)
čeština (CS) (192.56 KB - PDF)
dansk (DA) (151.57 KB - PDF)
Deutsch (DE) (152.17 KB - PDF)
eesti keel (ET) (147.88 KB - PDF)
ελληνικά (EL) (200.73 KB - PDF)
français (FR) (474.14 KB - PDF)
íslenska (IS) (151.76 KB - PDF)
italiano (IT) (148.51 KB - PDF)
latviešu valoda (LV) (202.11 KB - PDF)
lietuvių kalba (LT) (191.42 KB - PDF)
magyar (HU) (188.69 KB - PDF)
Malti (MT) (194.75 KB - PDF)
Nederlands (NL) (151.46 KB - PDF)
norsk (NO) (148.31 KB - PDF)
polski (PL) (176.01 KB - PDF)
português (PT) (151.81 KB - PDF)
română (RO) (188.05 KB - PDF)
slovenčina (SK) (195.92 KB - PDF)
slovenščina (SL) (189.87 KB - PDF)
Suomi (FI) (147.96 KB - PDF)
svenska (SV) (151.54 KB - PDF)

Product details

Name of medicine
Slentrol
Active substance
dirlotapide
International non-proprietary name (INN) or common name
dirlotapide
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QA08AB91

Pharmacotherapeutic group

Antiobesity preparations, excl. diet products

Therapeutic indication

As an aid in the management of overweight and obesity in adult dogs. To be used as part of an overall weight-management programme that also includes appropriate dietary changes and exercise practice.

Authorisation details

EMA product number
EMEA/V/C/000116
Marketing authorisation holder
Zoetis Belgium SA

Rue Laid Burniat 1
1348 Louvain-la-Neuve
Belgium

Marketing authorisation issued
13/04/2007
Revision
7

Assessment history

Slentrol : EPAR - Procedural steps taken and scientific information after authorisation

Slentrol : EPAR - Procedural steps taken before authorisation

Slentrol : EPAR - Scientific Discussion

This page was last updated on

How useful do you find this page?